Dermatologie souvent associée à la trisomie 21 - partie 1

Accueil
Contenus
Dermatologie souvent associée à la trisomie 21 – partie 1

Accueil
Contenus
Dermatologie souvent associée à la trisomie 21 – partie 1

01 Oct 2024

Médical & paramédical

PATHOLOGIES DERMATOLOGIQUES

Pathologies dermatologiques souvent associées à la trisomie 21 - partie 1

PLAN DU CHAPITRE

1- Dermatologie et trisomie 21 – introduction

2- Dermatologie courante et trisomie 21 – partie 1

3- Dermatologie courante et trisomie 21 – partie 2

4- Pathologies dermatologiques souvent associées à la trisomie 21 – partie 1

5- Pathologies dermatologiques souvent associées à la trisomie 21 – partie 2

6- Pathologies dermatologiques de survenue anecdotique dans la trisomie 21 (bientôt disponible)

Le docteur Hervé Walti, pédiatre à l’Institut Jérôme Lejeune, nous parle, dans cette vidéo et dans la fiche technique qui l’accompagne, de la dermatologie dans la trisomie 21.

Découvrez l’intégralité du chapitre « Pathologies dermatologiques » en cliquant sur “Plan du chapitre” à droite de l’image en haut de l’article.

Découvrez ci-dessous la présentation associée à cette vidéo.

Al-Dabbagh J, Younis R, Ismail N. The current available diagnostic tools and treatments of scabies and scabies variants : An updated narrative review. Medicine (Baltimore). 2023 May 26;102(21) :e33805.
Agarwal S, Guglani V, Kumar B. Down’s syndrome with lichen nitidus and segmental vitiligo. Indian J Dermatol Venereol Leprol. 2009 Nov-Dec;75(6) : 627-9.
Agarwal S, Gupta S, Ojha A, Sinha R. Childhood vitiligo : clinicoepidemiologic profile of 268 children from the Kumaun region of Uttarakhand, India. Pediatr Dermatol. 2013 May-Jun;30(3) : 348-53.
Aghaei S, Salmanpour R, Handjani F, Monabati A, Mazharinia N, Dastgheib L. Ulcerated disseminated cutaneous leishmaniasis associated with vitiligo, hypothyroidism, and diabetes mellitus in a patient with Down syndrome. Dermatol Online J. 2004 Oct 15;10(2):21.
Araya P, Waugh KA, Sullivan KD, Núñez NG, Roselli E, Smith KP, Granrath RE, Rachubinski AL, Enriquez Estrada B, Butcher ET, Minter R, Tuttle KD, Bruno TC, Maccioni M, Espinosa JM. Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity. Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24231-24241.
Armstrong AW, Read C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis : A Review. JAMA. 2020 May 19;323(19) : 1945-1960
Armstrong AW, Soliman AM, Betts KA, Wang Y, Gao Y, Puig L, Augustin M. Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis. Dermatol Ther (Heidelb). 2021 Jun;11(3):885-905.
Assaf RR, Wu H. Visual Diagnosis : Severe Scaly Pruritic Rash in an 8-year-old Girl With Trisomy 21. Pediatr Rev. 2016 Nov;37(11):e45-e47.
Aversa T, Valenzise M, Corrias A, Salerno M, Iughetti L, Tessaris D, Capalbo D, Predieri B, De Luca F, Wasniewska M. In children with autoimmune thyroid diseases the association with Down syndrome can modify the clustering of extra-thyroidal autoimmune disorders. J Pediatr Endocrinol Metab. 2016 Sep 1;29(9) :1041-6.
Bernigaud C, Fischer K, Chosidow O. The Management of Scabies in the 21st Century : Past, Advances and Potentials. Acta Derm Venereol. 2020 Apr 20;100(9) :adv00112.
Berk DR, Lu D, Lind AC, Bayliss SJ. Subsequent development of syringomas in a patient with milialike idiopathic calcinosis and without down syndrome. Arch Dermatol. 2010 Jun;146(6) :680-1.
Bibeau K, Pandya AG, Ezzedine K, Jones H, Gao J, Lindley A, Harris JE. Vitiligo prevalence and quality of life among adults in Europe, Japan and the USA. J Eur Acad Dermatol Venereol. 2022 Oct;36(10) :1831-1844.
Blok J, Jonkman M, Horváth B. The possible association of hidradenitis suppurativa and Down syndrome: is increased amyloid precursor protein expression resulting in impaired Notch signalling the missing link? Br J Dermatol. 2014 Jun;170(6):1375-7.
Botelho LF, Magalhães JP, Ogawa MM, Enokihara MM, Cestari Sda C. Generalized Lichen nitidus associated with Down’s syndrome: case report. An Bras Dermatol. 2012 May-Jun;87(3):466-8.
Brazzelli V, Segal A, Bernacca C, Tchich A, Bolcato V, Croci G, Mina T, Zecca M, Zanette S, Stronati M. Neonatal vesiculopustular eruption in Down syndrome and transient myeloproliferative disorder: A case report and review of the literature. Pediatr Dermatol. 2019 Sep;36(5):702-706.
Bronckers IM, Paller AS, van Geel MJ, van de Kerkhof PC, Seyger MM. Psoriasis in Children and Adolescents : Diagnosis, Management and Comorbidities. Paediatr Drugs. 2015 Oct;17(5) :373-84.
Butterworth T, Strean LP, Beerman H, Wood MG. Syringoma and mongolism. Arch Dermatol. 1964 Nov;90 :482-7.
Campos-Alberto E, Hirose T, Napatalung L, Ohyama M. Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database. J Dermatol. 2023 Jan;50(1):37-45.
Carter DM, Jegasothy BV. Alopecia areata and Down syndrome. Arch Dermatol. 1976 Oct;112(10):1397-9.
Cebeci D, Karasel S. Norwegian scabies in a child with Down syndrome. Sudan J Paediatr. 2021;21(2):215-218.
Cebeci F, Turgut Erdemir VA, Gürel MS, Akdeniz N, Aslan Kayıran M. Crusted scabies in a child with down syndrome. J Cosmet Dermatol. 2022 Nov;21(11):6466-6467.
Ceran B, Derme T, Orhan Erkan M, Sahin S, Gurlek Gokcebay D, Cakir U, Tayman C. A Down syndrome patient diagnosed with transient myeloproliferative disease after presenting with cutaneous findings. Ann Med Res 2021;28(10):1945-8.
Cestari SC, Petri V, Rotta O, Alchorne MM. Oral treatment of crusted scabies with ivermectin: report of two cases. Pediatr Dermatol. 2000 Sep-Oct;17(5):410-4.
Chen CH, Wang KH, Lin HC, Chung SD. Follow-up study on the relationship between alopecia areata and risk of autoimmune diseases. J Dermatol. 2016 Feb;43(2) :228-9.
Conrad C, Di Domizio J, Mylonas A, Belkhodja C, Demaria O, Navarini AA, Lapointe AK, French LE, Vernez M, Gilliet M. TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis. Nat Commun. 2018 Jan 2;9(1):25.
Daneshpazhooh M, Nazemi TM, Bigdeloo L, Yoosefi M. Mucocutaneous findings in 100 children with Down syndrome. Pediatr Dermatol. 2007 May-Jun;24(3):317-20.
Denny G, Anadkat MJ. Hidradenitis suppurativa (HS) and Down syndrome (DS) : Increased prevalence and a younger age of hidradenitis symptom onset. J Am Acad Dermatol. 2016 Sep;75(3) :632-634.
De Paoli RT, Marks VJ. Crusted (Norwegian) scabies: treatment of nail involvement. J Am Acad Dermatol. 1987 Jul;17(1):136-9.
Demirel Öğüt N , Eşme P, Çalışkan E. Hidradenitis suppurativa and psoriasis coexistence in
patients with Down syndrome: A case series. Gulhane Med J 2022;64:281-4.
Dhillon RK, Nguyen TH, Niemann A, Karai L, Skopit S. Keratotic Papules on a Patient With Down Syndrome. Am J Dermatopathol. 2023 Feb 1;45(2) :145-146.
Du Vivier A, Munro DD. Alopecia areata, autoimmunity, and Down’s syndrome. Br Med J. 1975 Jan 25;1(5951):191-2.
Engelman D, Yoshizumi J, Hay RJ, et al. The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies. Br J Dermatol. 2020 Nov;183(5) :808-820.
Enos T, Vasquez R, Vandergriff T, Wang R, Rainwater Y. Treatment of extensive elastosis perforans serpiginosa with acitretin in a man with Down syndrome. Int J Dermatol. 2021 May;60(5):611-612.
Ercis M, Balci S, Atakan N. Dermatological manifestations of 71 Down syndrome children admitted to a clinical genetics unit. Clin Genet. 1996 Nov;50(5):317-20.
Espinosa PS, Baumann RJ, Vaishnav AG. Elastosis perforans serpiginosa, Down syndrome, and moyamoya disease. Pediatr Neurol. 2008 Apr;38(4):287-8.
Estefan JL, Oliveira JC, Abad ED, Saintive SB, Porto LC, Ribeiro M. HLA antigens in individuals with down syndrome and alopecia areata. World J Clin Cases. 2014 Oct 16;2(10):541-5.
Ferrari M, Stagi S. Autoimmunity and Genetic Syndromes: A Focus on Down Syndrome. Genes (Basel). 2021 Feb 13;12(2):268.
Firsowicz M, Boyd M, Jacks SK. Follicular occlusion disorders in Down syndrome patients. Pediatr Dermatol. 2020 Jan;37(1):219-221.
Fonseca V, Price HN, Jeffries M, Alder SL, Hansen RC. Crusted scabies misdiagnosed as erythrodermic psoriasis in a 3-year-old girl with down syndrome. Pediatr Dermatol. 2014 Nov-Dec;31(6):753-4.
Fölster-Holst R, Rohrer T, Jung AM. Dermatological aspects of the S2k guidelines on Down syndrome in childhood and adolescence. J Dtsch Dermatol Ges. 2018 Oct;16(10):1289-1295.
Gach JE, Heagerty A. Crusted scabies looking like psoriasis. Lancet. 2000 Aug 19;356(9230):650.
Gansa W, Menon K, Sazeides C, Stewart O, Bogunovic D. Dysregulation of the Immune System in a Natural History Study of 1299 Individuals with Down Syndrome. Res Sq [Preprint]. 2023 Dec 4:rs.3.rs-3647800.
Garg A, Strunk A, Midura M, Papagermanos V, Pomerantz H. Prevalence of hidradenitis suppurativa among patients with Down syndrome : a population-based cross-sectional analysis. Br J Dermatol. 2018 Mar;178(3) :697-703.
Garg A, Neuren E, Cha D et al. Evaluating patients unmet needs in hidradenitis suppurativa : Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project. J Am Acad Dermatol. 2020 Feb;82(2) :366-376.
Garg A, Malviya N, Strunk A, et al.. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol. 2022 May;86(5):1092-1101.
Ghiasi M, Ghanadan A, Kalantari Y, Mahmoudi H, Etesami I. Generalized milia-like calcinosis cutis in a child with Down syndrome: dermoscopic features. Dermatol Online J. 2021 Feb 15;27(2) : 13030 /qt0bx294gm.
Gilhar A, Etzioni A, Paus R. Alopecia areata. N Engl J Med. 2012 Apr 19;366(16):1515-25.
Giovanardi G, Chiricozzi A, Bianchi L, De Simone C, Dini V, Franceschini C, Garcovich S, Oranges T, Di Raimondo C, Caposiena Caro DR, Romanelli M, Peris K. Hidradenitis Suppurativa Associated with Down Syndrome Is Characterized by Early Age at Diagnosis. Dermatology. 2018;234(1-2) :66-70.
Goksin S. Retrospective evaluation of clinical profile and comorbidities in patients with alopecia areata. North Clin Istanb. 2022 Oct 24;9(5):451-458.
Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021 Apr 3;397(10281) :1301-1315.
Grodner C, Miquel J, Hadj-Rabia S, Mallet S, Boralevi F, Mazereeuw-Hautier J, Benzebouchi N, Dhers M, Goujon E, Bensaïd P, Mahé E. Crusted scabies in children in France : a series of 20 cases. Eur J Pediatr. 2022 Mar;181(3) :1167-1174.
Gupta M. Eruptive syringomas in Down’s syndrome. Our Dermatol Online. 2018;9(2):174-175.
Haritha K, Rao GR, Attili SK. Down’s syndrome with annular lesions. Indian J Paediatr Dermatol 2023;24:83-4.
Hazini AR, Rongioletti F, Rebora A. Pityriasis rubra pilaris and vitiligo in Down’s syndrome. Clin Exp Dermatol. 1988 Sep;13(5):334-5.
Hedayati B, Carley SK, Kraus CN, Smith J. Arcuate pink plaques in a female with Down syndrome. Int J Dermatol. 2020 Apr;59(4):e127-e128.
Hernández-Rodríguez JC, Osorio-Gómez GF, Ortiz-Álvarez J, Lebrón-Martín JA, Conejo-Mir J, Pereyra-Rodríguez JJ. Hidradenitis suppurativa and Down syndrome in a single-centre sample : A cross-sectional study. Australas J Dermatol. 2022 Aug;63(3) :e231-e237.
Herzog V, Kirfel G, Siemes C, Schmitz A. Biological roles of APP in the epidermis. Eur J Cell Biol. 2004 Dec;83(11-12):613-24.
Honda M, Tomimura S, de Vega S, Utani A. Multiple dermatofibromas in a patient with Down syndrome. J Dermatol. 2016 Mar;43(3) :346-8.
Hye, M. A.; Dutta, S. S. Lichen Planus in Down Syndrome : Treatment With Systemic Retinoid – an Observation. Med. Today 2020, 32, 70-72.
Ingram JR. The epidemiology of hidradenitis suppurativa. Br J Dermatol. 2020 Dec;183(6) :990-998.
Jaffar H, Shakir Z, Kumar G, Ali IF. Ichthyosis vulgaris : An updated review. Skin Health Dis. 2022 Nov 25;3(1) :e187.
Jeon JJ, Jung SW, Kim YH, Parisi R, Lee JY, Kim MH, Lee WS, Lee S. Global, Regional, and National Epidemiology of Alopecia Areata : A Systematic Review and Modelling Study. Br J Dermatol. 2024 Feb 9 :ljae058.
Kanbara Y, Takeuchi C, Mochizuki Y, Osako M, Sasaki M, Miyake H. Medical Needs of Adults with Down Syndrome Presenting at a Regional Medical and Rehabilitation Center in Japan. J Nippon Med Sch. 2023 May 30;90(2):210-219.
Kim HO, Kang SY, Kim JC, Park CW, Chung BY. Pediatric Psoriasis : From New Insights into Pathogenesis to Updates on Treatment. Biomedicines. 2021 Aug 2;9(8) :940.
Kjaersgaard Andersen R, Saunte SK, Jemec GBE, Saunte DM. Psoriasis as a comorbidity of hidradenitis suppurativa. Int J Dermatol. 2020 Feb;59(2) :216-220.
Kopec AV, Levine N. Generalized connective tissue nevi and ichthyosis in Down’s syndrome. Arch Dermatol. 1979 May;115(5) :623-4.
Kranyak A, Rork J, Levy J, Burdick TE. Alopecia areata and thyroid screening in Down syndrome: Leveraging epic cosmos data set. J Am Acad Dermatol. 2023 Aug;89(2):360-361.
Krueger JG, Frew J, Jemec GBE, Kimball AB, Kirby B, Bechara FG, Navrazhina K, Prens E, Reich K, Cullen E, Wolk K. Hidradenitis suppurativa : new insights into disease mechanisms and an evolving treatment landscape. Br J Dermatol. 2024 Jan 23;190(2) :149-162.
Lam M, Lai C, Almuhanna N, Alhusayen R. Hidradenitis suppurativa and Down syndrome: A systematic review and meta-analysis. Pediatr Dermatol. 2020 Nov;37(6):1044-1050.
Lam M, Lu JD, Elhadad L, Sibbald C, Alhusayen RCommon Dermatologic Disorders in Down Syndrome: Systematic Review JMIR Dermatol 2022;5(1):e33391.
Lee JH, Chang JY, Lee KH. Syringoma : a clinicopathologic and immunohistologic study and results of treatment. Yonsei Med J. 2007 Feb 28;48(1) :35-40.
Lee K, Heresi G, Al Hammoud R. Norwegian Scabies in a Patient with Down Syndrome. J Pediatr. 2019 Jun;209:253-253.e1. doi: 10.1016/j.jpeds.2019.01.057. Epub 2019 Mar 8. PMID: 30853199.
Lopes ASA, Santos LDN, Razé MC, Lazzarini R. Alopecia areata: descriptive analysis in a Brazilian sample. An Bras Dermatol. 2022 Sep-Oct;97(5):654-656.
Madani A, Almuhaideb Q. Adalimumab Therapy in a Patient with Psoriasis, Down Syndrome, and Concomitant Hepatitis B Virus Infection. Biologics. 2021 Sep 1;15:375-378.
Malle L, Patel RS, Martin-Fernandez M, Stewart OJ, et al.. Autoimmunity in Down’s syndrome via cytokines, CD4 T cells and CD11c+ B cells. Nature. 2023 Mar;615(7951):305-314.

Mantero NM, Jaime LJ, Nijamin TR, Laffargue JA, De Lillo L, Grees SA. Sarna noruega en un paciente pediátrico con síndrome de Down: A propósito de un caso [Norwegian scabies in a pediatric patient with Down syndrome, a case report]. Arch Argent Pediatr. 2013 Dec;111(6):e141-3. Spanish.
Martora F, Fabbrocini G, Picone V, Blasio C, Ruggiero A, Megna M. A case of linear psoriasis in a young patient with Down syndrome and review of the literature. J Cosmet Dermatol. 2023 Feb;22(2):686-688.
Mauro A, Colonna C, Taranto S, Garella V, Castelletti F, Giordano L, Monzani NA, Bernardo L. The hidden scabies: a rare case of atypical Norwegian scabies, case report and literature review. Ital J Pediatr. 2024 Jan 17;50(1):7.
Mebazaa A, Ben Hadid R, Cheikh Rouhou R, Trojjet S, El Euch D, Mokni M, Zitouna M, Ben Osman A. Hidradenitis suppurativa : a disease with male predominance in Tunisia. Acta Dermatovenerol Alp Pannonica Adriat. 2009 Dec;18(4) :165-72.
McMichael J, Stoff BK. Treatment of a perforating dermatosis with apremilast. JAAD Case Rep. 2021 Sep 8;16:155-157. doi: 10.1016/j.jdcr.2021.08.031. PMID: 34632026; PMCID: PMC8488176.
Moar A, Maurelli M, Colato C, Schena D, Girolomoni G. Milia-like calcinosis cutis in Down syndrome : a new case with a review of the literature. Dermatol Online J. 2021 Aug 15;27(8).
Molinelli E, Sapigni C, D’agostino GM, Brisigotti V, Campanati A, Offidani A. Renbök phenomenon in a Down syndrome patient with hidradenitis suppurativa and alopecia areata. Eur J Dermatol. 2020 Aug 1;30(4) :435-436.
Monteagudo B, Alvarez-Fernández JC, Iglesias B, de las Heras C, Cacharrón JM. Dermatofibromas eruptivos múltiples en un paciente con síndrome de Down [Multiple eruptive dermatofribromas in a patient with Down’s syndrome]. Actas Dermosifiliogr. 2005 Apr;96(3):199. Spanish.
Monteagudo B, Suárez-Amor O, Cabanillas M, León-Mateos A, Pérez-Valcárcel J, de las Heras C. Síndrome de Down : ¿otra causa de inmunosupresión asociada con dermatofibromas eruptivos múltiples? [Down syndrome : another cause of immunosuppression associated with multiple eruptive dermatofibromas?]. Dermatol Online J. 2009 Sep 15;15(9) :15. Spanish.
Morita A, Kawakami Y, Kaji T, Hirai Y, Miyake T, Takahashi M, Yamasaki O, Sugiura K, Morizane S. Pediatric-onset annular pustular psoriasis in a patient with Down syndrome. J Dermatol. 2019 Oct;46(10):e367-e368.
Mostafa, N., Phan, K., Amin, T., & Smith, S. (2022). Hidradenitis Suppurativa and Down Syndrome : Systematic Review and Meta-Analysis. SKIN The Journal of Cutaneous Medicine, 6(3), 195–200.
Motegi SI, Sekiguchi A, Fujiwara C, Yamazaki S, Ishikawa O. Milia-like idiopathic calcinosis cutis and plaque-type syringoma in a girl with Down syndrome. J Dermatol. 2019 Apr;46(4) :e136-e137.
Lima Estefan J, Queiroz M, Costa FF, Coutinho MP, Higino K, Clinton Llerena J, Vargas FR, Santos S, Geller M, Ribeiro MG. Clinical characteristics of alopecia areata in Down syndrome. Acta Dermatovenerol Croat. 2013;21(4) :253-8.
Munera-Campos M, Vicente A, Rosende L, Rovira C. Lichen nitidus in a child receiving adalimumab for juvenile idiopathic arthritis. Indian J Dermatol Venereol Leprol. 2021 May-Jun;87(3) :408-409.
Murugaiyan R, Sengottian KL, Karthikeyan K. Crusted scabies presenting as palmoplantar psoriasis in Down’s syndrome. Indian Dermatol Online J. 2015 Mar-Apr;6(2):140-1.
Nagsuk P, Moore R, Lopez L. A case report of crusted scabies in an adult patient with Down syndrome. Dermatol Online J. 2015 Aug 15; 21(8) :13030/ qt4kc74256.
Narvaez-Rosales V, de-Ocariz MS, Carrasco-Daza D, Ramirez-Davila B, Orozco-Covarrubias L, Duran-McKinster C, Palacios-Lopez C. Neonatal vesiculopustular eruption associated with transient myeloproliferative disorder: report of four cases. Int J Dermatol. 2013 Oct;52(10):1202-9.
Ndiaye B, Develoux M, Dieng MT. La gale croûteuse (norvégienne) à Dakar (Sénégal) [Crusted (Norwegian) scabies in Dakar (Senegal)]. Sante. 1999 Jul-Aug;9(4):243-8. French.
Nomura K. Ichthyosis and psoriasis in a patient with Down syndrome. J Dermatol. 1999 Aug;26(8) :538-40.
O’Connor C, Byrne B, Roche D, O’Connell G, O’Connell M, Murphy M, Bourke J, Lynch M, Bennett M. Biological and JAK inhibitor therapy outcomes for severe psoriasis in trisomy 21. J Dermatol. 2023 Oct;50(10):1339-1342.
Patel D, Li P, Bauer AJ, Castelo-Soccio L. Screening Guidelines for Thyroid Function in Children With Alopecia Areata. JAMA Dermatol. 2017 Dec 1;153(12):1307-1310.
Patrizi A, Di Lernia V, Pauluzzi P. Lichen niditus généralisé, trisomie 21 et mégacôlon congénital [Generalized lichen niditus, trisomy 21 and congenital megacolon]. Ann Dermatol Venereol. 1991;118(10):725. French.
Payette MJ, Weston G, Humphrey S, Yu J, Holland KE. Lichen planus and other lichenoid dermatoses : Kids are not just little people. Clin Dermatol. 2015 Nov-Dec;33(6) :631-43.
Pereira AC, Baeta IG, Costa Júnior SR, Gontijo Júnior OM, Vale EC. Elastosis perforans serpiginosa in a patient with Down’s syndrome. An Bras Dermatol. 2010 Sep-Oct;85(5):691-4.
Peterson JA, Dowdle TS, Boothe WD, Austin BA, Stetson CL. Generalized lichen nitidus in a 6-year-old girl with Down syndrome. Proc (Bayl Univ Med Cent). 2021 Aug 25;35(1) :70-72.
Pikora TJ, Bourke J, Bathgate K, Foley KR, Lennox N, Leonard H. Health conditions and their impact among adolescents and young adults with Down syndrome. PLoS One. 2014 May 12;9(5):e96868.
Pirgon O, Atabek ME, Sert A. Diabetic ketoacidosis, thyroiditis and alopecia areata in a child with Down syndrome. Indian J Pediatr. 2009 Dec;76(12) :1263-4. doi : 10.1007/s12098-009-0242-7. Epub 2009 Dec 11.
PNDS ichthyoses héréditaires , HAS 2021. Téléchargeable sur www.has-sante.fr
Poizeau F, Sbidian E, Mircher C, Rebillat AS, Chosidow O, Wolkenstein P, Ravel A, Hotz C. Prevalence and Description of Hidradenitis Suppurativa in Down Syndrome : A Cross-sectional Study of 783 Subjects. Acta Derm Venereol. 2019 Mar 1;99(3) :351-352.
Polańska A, Bowszyc-Dmochowska M, Żaba RW, Adamski Z, Reich A, Dańczak-Pazdrowska A. Elastosis perforans serpiginosa: a review of the literature and our own experience. Postepy Dermatol Alergol. 2016 Oct;33(5):392-395.
Rachubinski AL, Estrada BE, Norris D, Dunnick CA, Boldrick JC, Espinosa JM. Janus kinase inhibition in Down syndrome : 2 cases of therapeutic benefit for alopecia areata. JAAD Case Rep. 2019 Apr 5;5(4) :365-367.
Ramba M, Bogunovic D. The immune system in Down Syndrome: Autoimmunity and severe infections. Immunol Rev. 2024 Mar;322(1):300-310.
Ramot Y, Molho-Pessach V, Tenenbaum A, Zlotogorski A. Alopecia areata and down syndrome: a true association or a coincidence. Int J Trichology. 2013 Oct;5(4):227-8.
Revuz J. Disseminate recurrent folliculitis as the presenting picture of hidradenitis suppurativa. Ann Dermatol Venereol. 2017 Nov;144(11) :715-718.
Roldán-Franco MS, de Nitsch MJY, Sarti HM. Crusted scabies mimicking an acrodermatitis continua of Hallopeau. Bol Med Hosp Infant Mex. 2019;76(4):198-202. English.
Rork JF, Rashighi M, Harris JE. Understanding autoimmunity of vitiligo and alopecia areata. Curr Opin Pediatr. 2016 Aug;28(4) :463-9.
Rork JF, McCormack L, Lal K, Wiss K, Belazarian L. Dermatologic conditions in Down syndrome: A single-center retrospective chart review. Pediatr Dermatol. 2020 Sep;37(5):811-816.
Ryan C, Vellody K, Belazarian L, Rork JF. Dermatologic conditions in Down syndrome. Pediatr Dermatol. 2021 Nov;38 Suppl 2:49-57.
Sardana K, Bathula S, Khurana A. Which is the Ideal JAK Inhibitor for Alopecia Areata – Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib – Revisiting the Immunomechanisms of the JAK Pathway. Indian Dermatol Online J. 2023 Jun 28;14(4):465-474.
Schepis C, Barone C, Siragusa M, Pettinato R, Romano C. An updated survey on skin conditions in Down syndrome. Dermatology. 2002;205(3):234-8.
Schepis C, Barone C, Lazzaro Danzuso GC, Romano C. Alopecia areata in Down syndrome: a clinical evaluation. J Eur Acad Dermatol Venereol. 2005 Nov;19(6):769-70.
Schepis C, Siragusa M, Happle R. Psoriasis and alopecia areata in a Down syndrome patient : a Renbök phenomenon. Eur J Dermatol. 2017 Jun 1;27(3) :300-301
Schwartz C, Goodman MB. Lichen Nitidus. 2023 Jul 4. In : StatPearls [Internet]. Treasure Island (FL) : StatPearls Publishing; 2024 Jan.
Sechi A, Guglielmo A, Patrizi A, Savoia F, Cocchi G, Leuzzi M, Chessa MA. Disseminate Recurrent Folliculitis and Hidradenitis Suppurativa Are Associated Conditions: Results From a Retrospective Study of 131 Patients With Down Syndrome and a Cohort of 12,351 Pediatric Controls. Dermatol Pract Concept. 2019 Jul 31;9(3):187-194.
Seifi G, Kalantari Y, Etesami I. Multiple dermatofibromas, associated clinical and histological characteristics : A systematic review. J Dtsch Dermatol Ges. 2022 Dec;20(12) :1569-1579. doi : 10.1111/ddg.14888. Epub 2022 Dec 4.
Seneschal J, Speeckaert R, Taïeb A, et al. Worldwide expert recommendations for the diagnosis and management of vitiligo : Position statement from the international Vitiligo Task Force-Part 2 : Specific treatment recommendations. J Eur Acad Dermatol Venereol. 2023 Nov;37(11) :2185-2195. doi : 10.1111/jdv.19450. Epub 2023 Sep 15. PMID : 37715487.
Senterre Y, Jouret G, Collins P, Nikkels AF. Risankizumab-Aggravated Crusted Scabies in a Patient with Down Syndrome. Dermatol Ther (Heidelb). 2020 Aug;10(4):829-834.
Sibbald C. Alopecia Areata : An Updated Review for 2023. J Cutan Med Surg. 2023 May-Jun;27(3) :241-259.
Siragusa M, Romano C, Cavallari V, Schepis C. Localized elastosis perforans serpiginosa in a boy with Down syndrome. Pediatr Dermatol. 1997 May-Jun;14(3):244-6.
Société Française de Dermatologie 2019 : https://reco.sfdermato.org/fr/recommandations-hidradénite-suppurée (accès février 2024).
Skayem C, Majda A, Gary C et al. Severe Scabies : A French Multi-centre Study Involving 95 Patients with Crusted and Profuse Disease and Review of the Literature. Acta Derm Venereol. 2023 Mar 2;103 : adv00878.
Sokoloff A, Dykman M, Sokoloff G, Vellody K, Holland K, Rork J. If my hidradenitis had a voice, this is what it would say : the perspective of a young woman with Down syndrome and hidradenitis suppurativa. Br J Dermatol. 2023 Jul 17;189(2) :221-222.
Solak B, Kara RO, Vargol E. Milia-like calcinosis cutis in a girl with Down syndrome. An Bras Dermatol. 2016 Sep-Oct;91(5):655-657.
Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, Shapiro J. Alopecia areata : Disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2018 Jan;78(1) :1-12.
Sugiura K, Kitoh T, Watanabe D, Muto M, Akiyama M. Childhood-onset PsA in Down syndrome with psoriasis susceptibility variant CARD14 rs11652075. Rheumatology (Oxford). 2015 Jan;54(1):197-9.
Sureshbabu R, Kumari R, Ranugha S, Sathyamoorthy R, Udayashankar C, Oudeacoumar P. Phenotypic and dermatological manifestations in Down Syndrome. Dermatol Online J. 2011 Feb 15;17(2):3.
Tan E, Tay YK, Giam YC. A clinical study of childhood alopecia areata in Singapore. Pediatr Dermatol. 2002 Jul-Aug;19(4):298-301.
Tanaka M, Hoashi T, Serizawa N, Okabe K, Ichiyama S, Shinohara R, Funasaka Y, Saeki H. Multiple unilaterally localized dermatofibromas in a patient with Down syndrome. J Dermatol. 2017 Sep;44(9):1074-1076.
Tancredi V, Licata G, Calabrese G, Buononato D, De Rosa A, Argenziano G, Gambardella A. Down syndrome and biological treatments in dermatology: Efficacy and safety in our real-life experience and review of literature. Australas J Dermatol. 2023 May;64(2):285-288.
Tandeter H, Lazarov A, Phillip M. Case of the month : a 10-year-old boy with Down syndrome and ichthyosiform changes. Eur J Pediatr. 1997 Jun;156(6) : 501-2.
Tazi-Ahnini R, di Giovine FS, McDonagh AJ, Messenger AG, Amadou C, Cox A, Duff GW, Cork MJ. Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): evidence of association with alopecia areata in the Down syndrome region. Hum Genet. 2000 Jun;106(6):639-45.
Thean LJ, Kunalau TA, Steer AC, Engelman D. An 11-Month-Old Fijian Girl With Down Syndrome, Malnutrition, and Hyperkeratotic Skin Lesions. Clin Infect Dis. 2021 Jan 27;72(2):357-359.
Togawa Y, Nohira G, Shinkai H, Utani A. Collagenoma in Down syndrome. Br J Dermatol. 2003 Mar;148(3) : 596-7.
Turan E, Yurt N, Yeşilova Y, Tanrıkulu O. A rare association in Down syndrome : milialike idiopathic calcinosis cutis and palpebral syringoma. Cutis. 2016 Dec;98(6) :E22-E23.
Williams K, Shinkai K. Evaluation and management of the patient with multiple syringomas: A systematic review of the literature. J Am Acad Dermatol. 2016 Jun;74(6):1234-1240.e9.
Wylie GR, Burden D. Renbok phenomenon between psoriasis and alopecia areata. Clin Exp Dermatol. 2011 Oct;36(7):816-7.
Zakon SJ, McQuay RM. Norwegian scabies in a male mongoloid : report of a case and a review of the literature. Int J Dermatol. 1972 Jan-Mar;11(1) :8-15.
Zimmerman TJ, George SJ. Multiple Eruptive Dermatofibromas Associated With Down Syndrome. Cutis. 2022 Aug;110(2) :E21-E23.
Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, Ingram JR, Kanni T, Karagiannidis I, Martorell A, Matusiak Ł, Pinter A, Prens EP, Presser D, Schneider-Burrus S, von Stebut E, Szepietowski JC, van der Zee HH, Wilden SM, Sabat R; European Hidradenitis Suppurativa Foundation Investigator Group. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol. 2017 Nov;177(5) :1401-1409.